Measurements | Morselized bone group (43) | Structural iliac bone group (39) | P-value |
---|---|---|---|
Operative time (min) | 144.3 ± 23.6 | 215.3 ± 32.8 | 0.008 |
Blood loss (ml) | 337.2 ± 105.2 | 507.6 ± 167.6 | 0.003 |
Hospital stay (d) | 11.7 ± 2.1 | 14.5 ± 2.9 | 0.001 |
ESR | |||
Preoperative | 43.3 ± 11.8 | 54.3 ± 12.5 | 0.553 |
Postoperative | 21.2 ± 8.0* | 19.7 ± 8.1* | 0.898 |
Final follow-up | 11.0 ± 4.3* | 11.0 ± 4.6* | 0.874 |
CRP | |||
Preoperative | 35.6 ± 14.5 | 35.7 ± 15.8 | 0.724 |
Postoperative | 13.2 ± 5.3* | 17.4 ± 5.3* | 0.854 |
Final follow-up | 7.3 ± 2.3* | 6.6 ± 2.6* | 0.536 |
VAS | |||
Preoperative | 6.9 ± 0.9 | 6.8 ± 0.9 | 0.903 |
Postoperative | 2.8 ± 0.8* | 4.1 ± 0.9* | 0.352 |
3 months follow-up | 3.0 ± 0.7* | 2.9 ± 0.6* | 0.862 |
Final follow-up | 2.3 ± 0.9* | 2.4 ± 0.8* | 0.417 |
Cobb (°) | |||
Preoperative | 3.1 ± 6.8 | 3.1 ± 5.2 | 0.136 |
Postoperative | 13.4 ± 4.8* | 12.6 ± 4.7* | 0.99 |
Final follow-up | 10.9 ± 4.0* | 11.1 ± 4.4* | 0.500 |
Bone graft fusion time (m) | 5.1 ± 1.7 | 4.7 ± 1.6 | 0.857 |
Fusion rate | 95% (41/43) | 97% (38/39) | 0.617 |
ASIA scores | |||
C | 0 | 0 | 0.502 |
D | 1 | 2 | |
E | 42 | 37 | |
Complications | 4(9.3%) | 10 (25.1%) | 0.051 |